Get Started
Definium Therapeutics, Inc.(DFTX)
NASDAQ
$33.27
2.91 (9.59%)

Definium Therapeutics, Inc.(DFTX)Company Profile & Business
NASDAQ

Company Profile

Business overview, scale, and footprint

Company NameDefinium Therapeutics, Inc.
Ticker SymbolDFTX
ExchangeNMS
SectorHealthcare
IndustryBiotechnology
Employees105
CEOMr. Robert Barrow
FoundedN/A
HeadquartersNew York, NY, United States
CountryUnited States
Websitedefiniumtx.com
Next Earnings DateNov 9, 2026

Business Overview

Definium Therapeutics, Inc., a clinical biopharmaceutical company, develops novel product candidates to treat brain health disorders. The company's lead product candidates DT120, which is in phase 3 for the treatment of generalized anxiety disorder, major depressive disorder, and other brain health disorders; and DT402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase 2a clinical trials for the treatment of autism spectrum disorder.

The company was formerly known as Mind Medicine (MindMed) Inc. and changed its name to Definium Therapeutics, Inc. in January 2026. Definium Therapeutics, Inc. is headquartered in New York, New York.

Insider Transactions

Open-market purchases and sales reported on SEC Form 4

Insider Activity Summary

Between Mar 25, 2026 and Sep 25, 2026, insiders of Definium Therapeutics, Inc. (DFTX) reported 12 open-market trades on SEC Form 4: 0 purchases (0 shares) and 12 sales (148,100 shares, about $5.79M). Sales exceeded purchases by about $5.79M.

12 open-market insider trades found. Showing 10 of 12.

Show:entries
Insider NameRelation to CompanyShares ChangedPriceTransaction Date
Karlin DanielChief Medical Officer-10,853$36.57Sep 25, 2026
Barrow RobertChief Executive Officer-31,550$36.57Sep 25, 2026
Wiley Matthew T.Chief Commercial Officer-3,097$36.57Sep 25, 2026
Sullivan MarkChief Legal Officer-14,051$36.57Sep 25, 2026
Roberts BrandiChief Financial Officer-3,377$36.57Sep 25, 2026
Unknown InsiderChief Executive Officer-19,023$37.94Sep 3, 2026
Unknown InsiderChief Commercial Officer-2,867$45.03Jun 25, 2026
Unknown InsiderChief Financial Officer-3,013$45.03Jun 25, 2026
Unknown InsiderChief Medical Officer-10,035$45.03Jun 25, 2026
Unknown InsiderChief Legal Officer-13,008$45.03Jun 25, 2026
Page 1 of 2 (12 total transactions)

Explore More Analysis for DFTX

Additional research, tools, and technical breakdowns

Stock Analyzer Report

Deep-dive automated research and stock rating report.

DCF Fair Value Calculator

Discounted cash flow model and intrinsic value projection.

AI Price Predictions

Multi-scenario price predictions and consensus targets.

Insider Activity Tracker

Track buying/selling behavior of corporate insiders.

Earnings Calendar

Track upcoming and historical corporate earnings reports.

Market Insights & Research

Read the latest analysis articles and expert research.

Latest TickZen Insights

All TickZen Insights →

Analysis Tools

→ Run DFTX Stock Analyzer→ DFTX DCF Fair Value Calculator→ DFTX Algorithmic Stock Forecast→ Earnings Calendar→ Insider Activity Tracker

Insights & Resources

→ Latest Market Insights & Research→ Market News & Bulletins→ How Tickzen Forecasting Works→ Frequently Asked Questions